SMR
NuScale Power CorporationThesis. NuScale owns the only NRC-approved SMR design and ~$884M net cash buying roughly five years of runway, but Q1'26 revenue of just $565K against a $3.1B market cap makes this a pre-revenue call option on AI datacenter power demand. With Fluor liquidating its entire stake at ~$12, 22.8% short interest, and shares pinned at the 52-week low, we stay on the sidelines pending a signed firm commercial PPA.
Scoreboard
SMR trades at $8.96, a hair above its $8.64 52-week low and 84% below the $57.42 high, sitting in the 1st percentile of its annual range. The $3.1B market cap capitalizes a company generating $565K of quarterly revenue — a 166x price-to-sales multiple — yet the Street's $15.36 mean target implies 71% upside, exposing a wide valuation-versus-fundamentals gap the market is presently resolving to the downside.
QoQ Changes
Q1'26 revenue collapsed to $565K from $1.81M in Q4'25 (-69% QoQ) and off a $8.24M Q3'25 peak as milestone recognition dried up. Basic EPS printed -$0.14, missing the -$0.129 consensus by 8.8% and extending a four-quarter miss streak.
Gross profit was a nominal $21K (3.7% gross margin) versus a negative print in Q4'25, but the trailing operating margin remains catastrophic near -102%. EBITDA of -$57.2M in Q1'26 improved off the -$538M Q3'25 impairment trough yet confirms a structurally pre-profit business.
Free cash flow margin is deeply negative (~-8.7x revenue) and cash burn continues, with the -$44M quarterly net loss a fair proxy for the operating drain. Management guides to ~$1.2B liquidity supporting roughly five years of runway, deferring rather than removing financing risk.
The balance sheet is the thesis's anchor: $890M cash against just $5.7M total debt yields $884M net cash and a 29.4x current ratio. Book value is $3.67/share and cash alone covers $2.57/share, capping downside but not eliminating dilution risk.
At 166x sales, 116x EV/revenue and a negative -13.4x forward P/E, conventional multiples are meaningless; the stock is valued on optionality, not earnings. Price-to-book of 2.4x is the only anchored metric and screens rich for a cash-burning developer.
Recent actions skew constructive: the ENTRA1 commercial partnership, a Mirion/Paragon protection-system award (12 modules already in production), the 12th E2 training center at UVA-Wise, and Korea/Romania deployment talks. Board additions of ex-NRC chairman Dale Klein and Stuart Harshaw add regulatory and operational credibility.
Ownership & Insider Activity
The dominant signal is bearish: strategic backer Fluor Corp fully liquidated its stake across three April open-market sales totaling ~$475M (13.5M shares at $12.07, 12.9M at $11.63, 13.5M at $11.81), zeroing its holding and removing a cornerstone sponsor. Subsequent 'insider' activity is entirely non-economic Form 4 director stock awards (code A, $0 price), so there is no offsetting open-market buying. Short interest at 22.8% of float — rising to 69.5M shares from 59.8M the prior month — signals aggressive positioning against the name, though the 1.97 short ratio preserves squeeze potential on a positive catalyst.
Recent Insider Transactions
| Date | Insider | Position | Shares | Value |
|---|---|---|---|---|
| 2026-06-30 | BOECKMANN ALAN L | Director | 3,681 | $0.00 |
| 2026-06-30 | KRESA KENT | Director | 2,702 | $0.00 |
| 2026-06-30 | HAMADY ROBERT RAMSEY | Chief Financial Officer | 20,000 | $202.8K |
| 2026-06-30 | HAMADY ROBERT RAMSEY | Chief Financial Officer | 20,000 | $64.0K |
| 2026-06-02 | FUJINO SHINJI | Director | 8,681 | $0.00 |
| 2026-05-29 | BOECKMANN ALAN L | Director | 8,681 | $0.00 |
Earnings Quality
| Period | Actual EPS | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
| 2026-03-31 Q1 | $-0.14 | $-0.13 | $-0.01 | -8.78% |
| 2025-12-31 Q4 | $-0.31 | $-0.12 | $-0.19 | -148.20% |
| 2025-09-30 Q3 | $-1.85 | $-0.14 | $-1.71 | -1197.34% |
| 2025-06-30 Q2 | $-0.13 | $-0.11 | $-0.02 | -13.44% |
NuScale missed consensus in all four of the last four quarters (0% beat rate) with an average surprise of -342%, distorted by the -1,197% Q3'25 miss on a $538M operating charge — evidence of both lumpy milestone accounting and persistent analyst miscalibration.
Excluding the Q3'25 impairment outlier, misses have narrowed toward the -9% to -13% range, suggesting the cost base is becoming more predictable even as the top line stays negligible — a modest positive read on guidance management.
Analyst Action
| Month | Distribution | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|---|
| 2026-07 | 1 | 9 | 10 | 1 | 1 | |
| 2026-06 | 1 | 9 | 10 | 1 | 1 | |
| 2026-05 | 1 | 9 | 10 | 1 | 1 | |
| 2026-04 | 1 | 9 | 9 | 1 | 1 |
The rating mix has been essentially frozen across April-July 2026 at roughly 10 Buy/Strong Buy versus 12 Hold/Sell, with Holds ticking from 9 to 10 since April — a marginal drift toward caution. Price targets have been trimmed, with one cut to ~$15.98 in June.
Momentum is neutral-to-mildly-bearish: no upgrades or downgrades in the trailing 15 days against a Hold-leaning skew.
Seven Essential Metrics
ROE of -83% and operating margin near -102%, with EBITDA of -$57M in Q1'26 and no visible path to profitability in current data.
Revenue growth of -95.8% YoY as milestone revenue lapsed; no commercial reactor revenue base yet exists.
FCF margin is deeply negative (~-8.7x revenue) and FCF yield is -5.2% — a pure cash-consumption profile.
$884M net cash, only $5.7M total debt and a 29.4x current ratio — effectively debt-free.
Beta of 2.25, 22.8% short interest and pre-revenue status make this a high-volatility, binary-outcome equity despite low balance-sheet risk.
166x P/S, 116x EV/revenue and a negative -13.4x forward P/E leave the stock priced on narrative, not fundamentals.
No buyback; equity-funded burn plus ongoing director/employee stock awards structurally dilute holders.
All cash is directed at commercialization; no capital-return capacity or intent.
Competitive Snapshot
| Company | EBITDA Margin | 3Y Rev CAGR | FCF Margin | Leverage | Fwd P/E |
|---|---|---|---|---|---|
OKLO Oklo Inc. | Negative | Pre-revenue | Negative | Net cash | n/a (loss) |
X-ENERGY X-Energy (recent IPO) | Negative | Early-stage | Negative | Net cash | n/a (loss) |
BWXT BWX Technologies | ~20% | ~8% | ~10% | ~1.5x | ~28x |
CEG Constellation Energy | ~25% | ~5% | ~12% | ~1.5x | ~28x |
Against pre-revenue SMR peers Oklo and newly-public X-Energy, NuScale's edge is its NRC design certification and fabrication head-start (12 modules in production), but Oklo's aggressive customer-agreement pipeline is winning the momentum narrative. Versus cash-flow-positive nuclear proxies BWXT and Constellation, SMR offers pure optionality with none of the earnings support — appropriate only for investors explicitly buying the SMR call option rather than nuclear cash flows.
Business & Strategy
Revenue is lumpy and milestone-driven, tied to licensing, design and engineering services around the 77-MWe NuScale Power Module rather than recurring product sales. Segment reporting is immaterial at $565K quarterly; commercial reactor economics remain prospective.
Target customers are utilities, governments (Romania, South Korea talks) and industrial/datacenter power buyers via the ENTRA1 commercial channel.
Near-term streams are engineering, regulatory licensing support, training (E2 centers) and equipment procurement; long-term upside is per-module fabrication and lifecycle O&M services once plants deploy.
Costs are dominated by R&D, regulatory/licensing spend and long-lead component fabrication with EPC partners.
The moat is regulatory: NuScale holds the only U.S. NRC-approved SMR design, a multi-year, high-barrier certification lead. That advantage erodes if competitors clear licensing or if first-mover deployment slips, converting the moat into a stranded R&D asset.
Monetary-Policy Sensitivity
- Long-duration equity — value concentrated in distant cash flows discounted at lower rates
- Improved project-finance economics for capital-intensive nuclear buildouts
- Risk-on rotation into speculative energy-transition names
As a profitless, long-duration story with a 2.25 beta, SMR is acutely sensitive to the discount rate and would outperform on dovish surprises. Conversely, higher-for-longer rates compress the present value of far-off module cash flows and pressure the thematic bid.
SWOT Analysis
- Only NRC-certified U.S. SMR design — durable regulatory moat
- $884M net cash, effectively debt-free, ~5-year runway
- 12 power modules already in fabrication with EPC partners
- Enhanced board credibility (ex-NRC chair Dale Klein)
- Negligible revenue ($565K in Q1'26) against a $3.1B cap
- Persistent operating losses and deeply negative FCF
- Four consecutive EPS misses; lumpy milestone accounting
- No signed firm commercial PPA generating deployment revenue
- AI datacenter power demand driving clean-baseload interest
- International deployments (Romania, South Korea) and ENTRA1 channel
- Ebara compressor and industrial off-grid applications
- Potential DOE/policy tailwinds and loan-guarantee support
- Fluor's full ~$475M exit removes cornerstone sponsorship
- Intensifying competition from Oklo and X-Energy
- 22.8% short interest amid an 84%-off-high downtrend
- Ongoing litigation and execution/schedule slippage risk
Catalysts & Event Risks
- Q2 2026Q2'26 earnings
Next quarterly print tests whether cash burn and milestone revenue stabilize; a fifth straight miss would pressure the thematic bid.
- 2026-11-01Potential overhang removal
Press speculation flags a major overhang possibly clearing 'before November,' a candidate sentiment inflection.
- Q3 2026Firm commercial PPA / reactor order
A signed PPA or reactor order would convert the design moat into revenue visibility — the key re-rating trigger.
- Q4 2026International deployment decisions
Romania and South Korea project advancement could validate the export pipeline.
- Q3 2026Short-squeeze setup
With 22.8% of float short and a 1.97 short ratio, any hard catalyst could force aggressive covering.
The binary catalyst is a firm commercial PPA — until one is signed, quarterly prints simply mark the pace of cash burn. Elevated short interest asymmetrically sharpens the reaction to any positive surprise.
Technical Analysis
SMR is in a well-established downtrend, trading at $8.96 versus a $11.27 50-day and $19.29 200-day average — a deeply bearish moving-average stack. Price sits in the 1st percentile of its 52-week range, just above the $8.64 low that now defines critical support; a decisive break opens air below toward the ~$2.57/share cash floor. Reclaiming the $11.27 50-day is the first hurdle to neutralize the trend. Risk-reward is a knife-edge: bounded fundamental downside from net cash against a violent downtrend and heavy short positioning.
Verdict
Macro context. The AI-driven surge in datacenter electricity demand is the structural tailwind underpinning nuclear and SMR equities, but a higher-for-longer rate regime penalizes profitless, long-duration developers most acutely. Policy support (DOE, loan guarantees) remains a swing factor for sector project economics.
NuScale is the regulatory leader in a compelling secular theme, backed by a fortress balance sheet that removes near-term solvency risk — but at 166x sales with $565K of quarterly revenue, this is a pre-commercial call option, not an investable business. Fluor's complete ~$475M exit, four straight EPS misses, and a stock pinned at its 52-week low argue against chasing here, while $884M net cash and 71% consensus upside argue against shorting into 22.8% short interest. We rate SMR HOLD with a $10.50 target, and would upgrade only on a signed firm commercial PPA that converts the design moat into revenue visibility.
Data source: Yahoo Finance / yfinance · fetched 7/8/2026, 6:55:55 AM